Myasthenia Gravis Treatment Market Sees Uptick in Pediatric Care Demand
The global myasthenia gravis treatment market size was estimated at USD 2.01 billion in 2022 and is projected to reach USD 4.26 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.0% from 2023 to 2030. Key factors fueling this growth include the increasing adoption of immunotherapies, approval of innovative drugs, the emergence of biologics, and heightened...
0 Comments 0 Shares 16 Views 0 Reviews